"We are working with the government and trying to find constructive solutions so that Americans pay less for their medicines."
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
April 29, 2025
Trump’s plan for hefty tax on imported drugs risks higher prices and shortages
BY PAUL WISEMAN, TOM MURPHY AND OTHERS
September 1, 2025
Company will sell some medicines at a discount to government’s Medicaid health plan in exchange for tariff relief
Chief executive Pascal Soriot applauds the deal with Donald Trump as ‘a big win’ for US patients
Pascal Soriot refuses to be drawn, however, on reports AZ could move its main stock market listing across the Atlantic
The head of the pharmaceutical giant warns that Europe's decline in manufacturing innovative medicines is likely to accelerate as…
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal, following Pfizer's similar agreement.
The continent's pharma sector could be one of its worst hit by Trump's latest tariffs on some European countries.
